Literature DB >> 31326230

Bystander activation and autoimmunity.

Yovana Pacheco1, Yeny Acosta-Ampudia1, Diana M Monsalve1, Christopher Chang2, M Eric Gershwin3, Juan-Manuel Anaya4.   

Abstract

The interaction over time of genetic, epigenetic and environmental factors (i.e., autoimmune ecology) increases or decreases the liability an individual would have to develop an autoimmune disease (AD) depending on the misbalance between risk and protective effects. Pathogens have been the most common antecedent events studied, but multiple other environmental factors including xenobiotic chemicals, drugs, vaccines, and nutritional factors have been implicated into the development of ADs. Three main mechanisms have been offered to explain the development of autoimmunity: molecular mimicry, epitope spreading, and bystander activation. The latter is characterized by auto-reactive B and T cells that undergo activation in an antigen-independent manner, influencing the development and course of autoimmunity. Activation occurs due to a combination of an inflammatory milieu, co-signaling ligands, and interactions with neighboring cells. In this review, we will discuss the studies performed seeking to define the role of bystander activation in systemic and organ-specific ADs. In all cases, we are cognizant of individual differences between hosts and the variable latency time for clinical expression of disease, all of which have made our understanding of the etiology of loss of immune tolerance difficult and enigmatic.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Auto-reactive T cells; Autoimmune diseases; Bystander activation; Cytokines; Infection; T-cell activation

Year:  2019        PMID: 31326230     DOI: 10.1016/j.jaut.2019.06.012

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  27 in total

Review 1.  Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

Authors:  Geoffrey D E Cuvelier; Michelle Schoettler; Nataliya P Buxbaum; Iago Pinal-Fernandez; Marc Schmalzing; Jörg H W Distler; Olaf Penack; Bianca D Santomasso; Robert Zeiser; Klemens Angstwurm; Kelli P A MacDonald; W Taylor Kimberly; Naomi Taylor; Ervina Bilic; Bernhard Banas; Maike Buettner-Herold; Namita Sinha; Hildegard T Greinix; Joseph Pidala; Kirk R Schultz; Kirsten M Williams; Yoshihiro Inamoto; Corey Cutler; Linda M Griffith; Stephanie J Lee; Stefanie Sarantopoulos; Steven Z Pavletic; Daniel Wolff
Journal:  Transplant Cell Ther       Date:  2022-05-31

Review 2.  Long COVID: current status in Japan and knowledge about its molecular background.

Authors:  Akihiro Matsunaga; Shinya Tsuzuki; Shinichiro Morioka; Norio Ohmagari; Yukihito Ishizaka
Journal:  Glob Health Med       Date:  2022-04-30

Review 3.  Pathophysiological Role of Nucleic Acid-Sensing Pattern Recognition Receptors in Inflammatory Diseases.

Authors:  Norisuke Kano; Guang Han Ong; Daisuke Ori; Taro Kawai
Journal:  Front Cell Infect Microbiol       Date:  2022-06-06       Impact factor: 6.073

4.  Narcolepsy type 1 comorbid with myasthenia gravis: possible immunological link.

Authors:  Sally El Sammak; Veronica Cipriani; Ashima Sahni; Hrayr Attarian
Journal:  J Clin Sleep Med       Date:  2022-07-01       Impact factor: 4.324

Review 5.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

Review 6.  Immunogenicity of CAR T cells in cancer therapy.

Authors:  Dimitrios L Wagner; Enrico Fritsche; Michael A Pulsipher; Nabil Ahmed; Mohamad Hamieh; Meenakshi Hegde; Marco Ruella; Barbara Savoldo; Nirali N Shah; Cameron J Turtle; Alan S Wayne; Mohamed Abou-El-Enein
Journal:  Nat Rev Clin Oncol       Date:  2021-02-25       Impact factor: 66.675

7.  Eruptive Halo Naevi: A Possible Indicator of Malignant Disease in a Case Series of Post-Adolescent Patients.

Authors:  Henrik F Lorentzen
Journal:  Acta Derm Venereol       Date:  2020-08-17       Impact factor: 3.875

Review 8.  Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.

Authors:  Yhojan Rodríguez; Lucia Novelli; Manuel Rojas; Maria De Santis; Yeny Acosta-Ampudia; Diana M Monsalve; Carolina Ramírez-Santana; Antonio Costanzo; William M Ridgway; Aftab A Ansari; M Eric Gershwin; Carlo Selmi; Juan-Manuel Anaya
Journal:  J Autoimmun       Date:  2020-06-16       Impact factor: 7.094

9.  Reprogramming of microRNA expression via E2F1 downregulation promotes Salmonella infection both in infected and bystander cells.

Authors:  Carmen Aguilar; Susana Costa; Claire Maudet; R P Vivek-Ananth; Sara Zaldívar-López; Juan J Garrido; Areejit Samal; Miguel Mano; Ana Eulalio
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

10.  Extracellular Vesicles Derived Human-miRNAs Modulate the Immune System in Type 1 Diabetes.

Authors:  Tine Tesovnik; Jernej Kovač; Katka Pohar; Samo Hudoklin; Klemen Dovč; Nataša Bratina; Katarina Trebušak Podkrajšek; Maruša Debeljak; Peter Veranič; Emanuele Bosi; Lorenzo Piemonti; Alojz Ihan; Tadej Battelino
Journal:  Front Cell Dev Biol       Date:  2020-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.